| 0.4979 Data as of 4:00pm ET |  +0.0254 / +5.38%Today’s Change | 0.28 Today|||52-Week Range 0.81 | +60.61% Year-to-Date |
| Previous close | 0.47 |
| Today’s open | 0.49 |
| Day’s range | 0.47 - 0.50 |
| Volume | 1,451,090 |
| Average volume (3 months) | 795,961 |
| Market cap | $56.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | -50.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| CBRXColumbia Laboratorie... | -0.00 | -0.63% |
| CYCCCyclacel Pharmaceuti... | -0.04 | -1.27% |
| TSPTTranscept Pharmaceut... | +0.06 | +2.03% |
| --Hubei Minkang Pharma... | 0.00 | 0.00% |
| Last reporting date | March 22, 2013 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientist Chang Ho Ahn, PhD |
President & Chief Operating Officer Rakesh Soni, MBA |
Corporate headquarters Rockville, Maryland |
.
